 SCOTTSDALE, Ariz., Oct. 04, 2022 GLOBE NEWSWIRE -- Journey Medical Corporation Journey Medical Nasdaq: DERM, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, President and Chief Executive Officer, will participate in two upcoming investor conferences. 